Bumper Offer - Urjas oil Just @ Rs. 1
Zinodap M is an allopathic medicine The correct dosage of Zinodap M depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Zinodap M is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Zinodap M is used -
Severe
Moderate
Mild
Common
Is the use of Zinodap M safe for pregnant women?
Zinodap M can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Zinodap M safe during breastfeeding?
In the absence of any scientific study about the side effects of Zinodap M in breastfeeding women, information on safety of Zinodap M is unavailable.
What is the effect of Zinodap M on the Kidneys?
Kidney can be affected by Zinodap M. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Zinodap M on the Liver?
There may be an adverse effect on the liver after taking Zinodap M. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Zinodap M on the Heart?
Information about safety of Zinodap M for heart is not available since scientific research on this is yet to be done.
Zinodap M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zinodap M unless your doctor advises you to do so -
Is this Zinodap M habit forming or addictive?
Forming a habit of Zinodap M has not been reported.
Interaction between Food and Zinodap M
Due to the absence of research, it is difficult to say how Zinodap M and food will interact.
Interaction between Alcohol and Zinodap M
Consuming Zinodap M with alcohol can have many serious effects on your body.
Yes, Zinodap M can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
Zinodap M can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
Zinodap M works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
No, you should not take alcohol with Zinodap M, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Zinodap M than if you're just taking Zinodap M. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Yes, Zinodap M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Zinodap M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Zinodap M may need to be adjusted.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278